
Sign up to save your podcasts
Or


Medical innovation is often hindered by the high costs of clinical trials and the complexity of navigating government regulations and reporting requirements. For many companies, this prevents life-saving advances from reaching the market. Now, there is a way to accelerate human clinical trials and reduce development expenses. This represents one of the positive aspects of globalization. Julio Martinez-Clark, CEO of Bioaccess, is here today.
Key Takeaways To Tune In For:
(04:40) - Challenges of US Clinical Trials
(08:33) - Why Startups Look Overseas
(19:00) - Real-World Success Stories
(23:01) - Panama's Role in Innovation
(27:49) - Global Trial Accelerators Podcast
Resources talked about in this episode:
Website:
juliomartinezclark.com
bioaccessla.com
Podcast: Global Trial Accelerators
Social media handles: LinkedIn
By Dr. John Neustadt5
1818 ratings
Medical innovation is often hindered by the high costs of clinical trials and the complexity of navigating government regulations and reporting requirements. For many companies, this prevents life-saving advances from reaching the market. Now, there is a way to accelerate human clinical trials and reduce development expenses. This represents one of the positive aspects of globalization. Julio Martinez-Clark, CEO of Bioaccess, is here today.
Key Takeaways To Tune In For:
(04:40) - Challenges of US Clinical Trials
(08:33) - Why Startups Look Overseas
(19:00) - Real-World Success Stories
(23:01) - Panama's Role in Innovation
(27:49) - Global Trial Accelerators Podcast
Resources talked about in this episode:
Website:
juliomartinezclark.com
bioaccessla.com
Podcast: Global Trial Accelerators
Social media handles: LinkedIn

781 Listeners

380 Listeners

1,868 Listeners

488 Listeners

639 Listeners

3,928 Listeners

3,493 Listeners

9,295 Listeners

88 Listeners

8,178 Listeners

194 Listeners

2,080 Listeners

3,446 Listeners

20,212 Listeners

151 Listeners